ODM-209

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameODM-209
Drug Alias NameODM-209
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCytochrome P450 11A1 inhibitors
TargetsCytochrome P450 11A1
Therapy Area/IndicationsMetastatic breast cancerProstatic Neoplasms, Castration-ResistantProstatic Neoplasms +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryDenmarkFranceFinland
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesOrion Corp
China Registration ClassN/A

Develop Information

Active CompaniesOrion Corporation Orion Pharma
Inactive CompaniesN/A
Active IndicationsMetastatic breast cancerProstatic Neoplasms, Castration-ResistantProstatic Neoplasms +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A